THE PROPANORM EFFICACY IN RAPID RELIEF OF SYMPTOMS OF PAROXYSMAL AURICULAR FIBRILLATION

In aim to study efficacy and safety of propafenone (Propanorm), open prospective поп randomized study in-patients with paroxysmal form of auricular fibrillation (AF) was carried out. 31 patients - 16 men (51,6 % ) and 15 women (48,4 % ) with mean age 58, 1± 8 years were included in the study. The paroxysmal form AF was observed in 29 patients (93,5 % ), persistent form - in 2 patients (6,5 % ). The reason of arrhythmia in 21 patients (67,7 % ) was ischemic heart disease, in 12 patients (38,7 % >) - arterial hypertension, in 2 patients (6,4 % ) - rheumatic heart diseases, in 1 patient (3,2 % ) - idiopathic AF. The medication for rapid relief of symptoms of paroxysmal auricular fibrillation was administered in single stress dose 600 mg per os. Propanorm restored the rhythm in 74,2 % > patients. The disorder of intraventricular conduction on EKG became evi-dentin 7 patients (22,5 % ) in time from 2to 16. 5 hours (on average 5, 1 hour), atrioventricular heart block of I stage - in 2 patients (6,45 % ), aberrant ventricular complex - in 2 patients (6,45 % ), pacemaker migration and sinus bradycardia - in 1 patient (3,2 % ). This disorders eliminated independently without special intervention. Extracardiac side effects during single intake were not observed. Propafenone appeared to be high-performed antiarrhythmic medication in rapid relief of symptoms of paroxysmal auricular fibrillation. Its application is possible in the outpatient setting.

1. Олейников В.Э. Совершенствование диагностики и медикаментозной терапии пароксизмальной мерцательной аритмии, наджелудочковой тахикардии, экстрасистолии: Автореф. дис.... д-ра мед. наук. Пенза. 1995. 32 с.

2. Baekr B.J., Dinh H., Krosky D., et al. Effect of propafenone on left ventricular ejection fraction. Am. J. Cardiol. 1984; 54: 20D-22D.

3. Bianconi L., Boccadamo R., Pappalardo A., et al. Effectiveness of intravenous propafenon for conversion of atrial fibrillation and flutter of recent onset. Am. J. Cardiol. 1989; 64: 335-8.

4. Bianconi L., Dinelli M., Pappalardo A. Comparison of intravenously-Administrated dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicenter, randomized, double-blind, placebo-controlled study.//Circulation 1995, V. 92, Suppl. 1. P. 1-774.

5. Benajmim E., Levy D., Vaziri S., et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.//JAMA. 1994. V. 171. P. 840-844.

6. Boriani G., Biffi M., Capucci A., et al. Oral propafenon to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial. Ann. Intern. Med. 1997; 126: 621-5.

7. Donovan K., Power B., et al. Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation. Ann. J. Cardiol., 1995; 75: 693-697.

8. Fenster P.E., Comess К.A., Marsh R., et al. Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion. Am. Heart J.1983; 106: 501-504.

9. Fujki A., Yoshida S., Nani M., et al. Efficacy of Class la antiarhythmic drugs in converting atrial fibrillation unassociated with organic heart disease and their relation to atrial electrophysiologic characteristics. Am. J. Cardiol. 1994; 74: 282-283.

10. Halpern S.W., Ellrodt G., Singh B.N., et al. Efficacy of intravenous procainamide infusion on converting atrial fibrillation to sinus rhythm. Br. Heart J. 1980; 44: 589-595.

11. Hou Z., Chang M., Chen C., et al. Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing of intravenous amiodarone. Eur. Heart. J. 1995; 16: 521-528.

12. Madrid A., Moro C., et al. Comparison of flecainide and procainamide cardioversion of atrial fibrilfation. Eur. Heart J. 1993; 14: 1127-1131.

13. Martinez-Marcos F.J., Garcia-Gannendia J.L., Ortega-Carpio A.A., et al. Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm. Am. J. Cardiol. 1989; 86.

14. Shen E.N., Sungor R.J., Morady F., et al. Electrophysiologic at hemodynamic effects of intravenous propafenone in patients with recurrent ventricular tachycardia. J. Am. College Cardiol. 1984; 3: 1291-1297.